The use case: how Royalty Pharma deploys AlphaSense
Royalty Pharma's strategy and analytics team uses AlphaSense for genAI-powered search, automated data extraction, and a unified knowledge base that combines its internal diligence documents with AlphaSense's content library. This supports due diligence and research on biopharmaceutical investment opportunities.
In the customer’s words
Before AlphaSense, our analysts spent hours scanning hundreds of industry journals just to find that nugget of information that might make or break an investment thesis.AlphaSense users in Investment & VC
Companies in the same sector, with public evidence.
Recurve CapitalConfirmed
Aberdeen InvestmentsObserved
Chakra CapitalObserved
Goldman SachsObserved
SummitryObserved
Susquehanna International GroupObservedGo straight to the source
Based on AlphaSense’s published case study. We check the public evidence; the results are reported by the vendor.
alpha-sense.com- Last checked
- Nov 10, 2026
Open source capture What the story claims, and what we checked
What we compared with the page.
- The figure: 30%Checked
Printed word for word on the page, near the name of Royalty Pharma.
- The passage quoted aboveChecked
Copied word for word from the page, near the name of Royalty Pharma.
- Royalty Pharma uses AlphaSenseChecked
Confirmed line.
- The result itselfNot checked
We quote it; we did not measure it.
Working with AlphaSense has decreased the time this team needs to work by about 30% by having access to scientific publications, regulatory documents, patents, financial information, sell side notes, broker information — and now the game-changing access to genAI over all of that.
